Fruquintinib in Patients With Metastatic Colorectal Cancer: A Prospective, Multicenter, Observational Study
Latest Information Update: 29 Jan 2025
Price :
$35 *
At a glance
- Drugs Fruquintinib (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms FRUQUENT
- 29 Jan 2025 New trial record